Published in J Clin Microbiol on February 01, 1984
Cholera. Clin Microbiol Rev (1995) 12.33
Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp. Clin Microbiol Rev (1988) 4.76
Enterotoxicity of El Tor-like hemolysin of non-O1 Vibrio cholerae. Infect Immun (1987) 2.46
Genotypes associated with virulence in environmental isolates of Vibrio cholerae. Appl Environ Microbiol (2001) 2.41
Enterobacterial repetitive intergenic consensus sequences and the PCR to generate fingerprints of genomic DNAs from Vibrio cholerae O1, O139, and non-O1 strains. Appl Environ Microbiol (1995) 1.80
Vibriophage VcA-3 as an epidemic strain marker for the U.S. Gulf Coast Vibrio cholerae O1 clone. J Clin Microbiol (1992) 1.68
Genetic diversity among toxigenic and nontoxigenic Vibrio cholerae O1 isolated from the Western Hemisphere. Epidemiol Infect (1991) 1.61
Molecular epidemiology of non-O1 Vibrio cholerae and Vibrio mimicus in the U.S. Gulf Coast region. J Clin Microbiol (1986) 1.29
Cholera enterotoxin production in Vibrio cholerae O1 strains isolated from the environment and from humans in Japan. Appl Environ Microbiol (1991) 1.28
The human pathogenic vibrios--a public health update with environmental perspectives. Epidemiol Infect (1989) 1.26
Potent membrane-permeabilizing and cytocidal action of Vibrio cholerae cytolysin on human intestinal cells. Infect Immun (1997) 1.15
Neutrophils are essential for containment of Vibrio cholerae to the intestine during the proinflammatory phase of infection. Infect Immun (2012) 1.02
Gene encoding zonula occludens toxin (zot) does not occur independently from cholera enterotoxin genes (ctx) in Vibrio cholerae. J Clin Microbiol (1993) 1.02
Epidemiology of Klebsiella oxytoca-associated diarrhea detected by Simmons citrate agar supplemented with inositol, tryptophan, and bile salts. J Clin Microbiol (2012) 0.85
Promotion of colonization and virulence by cholera toxin is dependent on neutrophils. Infect Immun (2013) 0.82
Abundance and distribution of Vibrio cholerae, V. parahaemolyticus, and V. vulnificus following a major freshwater intrusion into the Mississippi Sound. Microb Ecol (2013) 0.79
Distribution of virulence genes in clinical and environmental Vibrio cholerae strains in Bangladesh. Appl Environ Microbiol (2013) 0.77
Cholera--a possible endemic focus in the United States. N Engl J Med (1980) 6.71
Molecular characterization of environmental and nontoxigenic strains of Vibrio cholerae. Infect Immun (1981) 4.45
A case of cholera in Texas, 1973. Am J Epidemiol (1974) 3.71
Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea. Infect Immun (1981) 3.69
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Use of Moore swabs for isolating Vibrio cholerae from sewage. J Clin Microbiol (1980) 2.36
Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med (1983) 25.72
Cholera. Clin Microbiol Rev (1995) 12.33
RADIOACTIVE IODINE AS AN INDICATOR IN THYROID PHYSIOLOGY. IV. THE METABOLISM OF IODINE IN GRAVES' DISEASE. J Clin Invest (1942) 11.36
Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med (1979) 10.57
Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol (1980) 10.44
The emergence of grade A eggs as a major source of Salmonella enteritidis infections. New implications for the control of salmonellosis. JAMA (1988) 7.35
Cholera--a possible endemic focus in the United States. N Engl J Med (1980) 6.71
Lay people's attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch. BMJ (1996) 6.31
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med (1988) 5.92
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Bacteriophage therapy. Antimicrob Agents Chemother (2001) 5.16
Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol (1982) 4.93
Oxygen and the growth and metabolism of Clostridium acetobutylicum. J Gen Microbiol (1971) 4.91
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell (2001) 4.79
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
GALEN ten years on: tasks and supporting tools. Stud Health Technol Inform (2001) 4.34
Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med (1988) 4.11
Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world. Epidemiol Rev (1996) 4.09
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Ann Intern Med (1984) 3.88
Clinical features and an epidemiological study of Vibrio vulnificus infections. J Infect Dis (1984) 3.69
Escherichia coli O157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings. J Infect Dis (1986) 3.62
Harlequin syndrome: the sudden onset of unilateral flushing and sweating. J Neurol Neurosurg Psychiatry (1988) 3.47
Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect Immun (1990) 3.47
Cholera in Africa: lessons on transmission and control for Latin America. Lancet (1991) 3.36
The molecular epidemiology of cholera in Latin America. J Infect Dis (1993) 3.26
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Taxonomy and description of Vibrio fluvialis sp. nov. (synonym group F vibrios, group EF6). J Appl Bacteriol (1981) 3.13
Heterosexually transmitted human immunodeficiency virus infection among pregnant women in a rural Florida community. N Engl J Med (1992) 3.08
Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellates. Lancet (1998) 3.03
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest (1987) 3.03
Prevalence of Escherichia coli strains with localized, diffuse, and aggregative adherence to HeLa cells in infants with diarrhea and matched controls. J Clin Microbiol (1989) 3.02
Illness associated with Campylobacter laridis, a newly recognized Campylobacter species. J Clin Microbiol (1985) 3.00
Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center. J Pediatr (1986) 2.98
Group F, a new Vibrio? Lancet (1977) 2.79
A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health (1996) 2.78
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73
Campylobacter enteritis at a university: transmission from eating chicken and from cats. Am J Epidemiol (1987) 2.70
The incidence of Vibrio cholerae in water, animals and birds in Kent, England. J Appl Bacteriol (1982) 2.61
Evaluation of DNA colony hybridization and other techniques for detection of virulence in Yersinia species. J Clin Microbiol (1989) 2.58
The protective effect of alcohol on the occurrence of epidemic oyster-borne hepatitis A. Epidemiology (1992) 2.55
Production of Solvents by Clostridium acetobutylicum Cultures Maintained at Neutral pH. Appl Environ Microbiol (1984) 2.51
Health and economic impacts of antimicrobial resistance. Rev Infect Dis (1988) 2.49
Back pain: a randomized clinical trial of rotational manipulation of the trunk. Br J Ind Med (1974) 2.47
Cholera on Guam, 1974: epidemiologic findings and isolation of non-toxinogenic strains. Am J Epidemiol (1977) 2.46
Ecology of Vibrio species, including Vibrio cholerae, in natural waters in Kent, England. J Appl Bacteriol (1982) 2.45
Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun (1995) 2.45
Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus. Infect Immun (1985) 2.42
Use of Moore swabs for isolating Vibrio cholerae from sewage. J Clin Microbiol (1980) 2.36
Staphylococcal food poisoning in the United States. New facts and old misconceptions. JAMA (1984) 2.35
Serotype-specific prevalence of Escherichia coli strains with EPEC adherence factor genes in infants with and without diarrhea in São Paulo, Brazil. J Infect Dis (1989) 2.35
Dual-component amino-acid-mediated synaptic potentials: excitatory drive for swimming in Xenopus embryos. J Physiol (1985) 2.34
Vibrio cholerae in Kent. Lancet (1979) 2.33
On the permeability to weak acids and bases of the cytoplasmic membrane of Clostridium pasteurianum. Biochem Biophys Res Commun (1981) 2.32
Epidemiology of common-source outbreaks of shigellosis in the United States, 1961-1975. Am J Epidemiol (1978) 2.30
Correlation between adherence to HeLa cells and serogroups, serotypes, and bioserotypes of Escherichia coli. Infect Immun (1985) 2.28
Enterotoxin production in relation to taxonomic grouping and source of isolation of Aeromonas species. J Clin Microbiol (1984) 2.27
Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study. JAMA (1988) 2.26
Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli. Infect Immun (1983) 2.26
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25
Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial. Ann Intern Med (1990) 2.25
Illness caused by Vibrio damsela and Vibrio hollisae. Lancet (1982) 2.17
A statewide outbreak of Escherichia coli O157:H7 infections in Washington State. Am J Epidemiol (1990) 2.13
Isolation of vancomycin-resistant enterococci from animal feed in USA. Lancet (1999) 2.12
Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl Environ Microbiol (1996) 2.10
An audit of clinical nurse practitioner led thrombolysis to improve the treatment of acute myocardial infarction. J Public Health Med (2000) 2.08
The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry (1999) 2.07
Non-O:1 Vibrio cholerae bacteremia: case report and review. Rev Infect Dis (1988) 2.07
Communitywide shigellosis: control of an outbreak and risk factors in child day-care centers. Am J Public Health (1995) 2.04
The use of gemeprost pessaries to arrest postpartum haemorrhage. Br J Obstet Gynaecol (1993) 2.04
Half-time and high-speed running in the second half of soccer. Int J Sports Med (2012) 2.03
Aeromonas intestinal infections in the United States. Ann Intern Med (1986) 2.03
Epidemic campylobacteriosis associated with a community water supply. Am J Public Health (1986) 2.02
Make an application for flexible (part time) training. BMJ (1995) 2.02
Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol Microbiol (1996) 2.01
Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA (1997) 1.99
Prevention of Russian influenza by amantadine. JAMA (1979) 1.97
Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med (1984) 1.96
Comparison of DNA probes and the Sereny test for identification of invasive Shigella and Escherichia coli strains. J Clin Microbiol (1986) 1.96
Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infect Immun (1999) 1.95
Utilization of L-threonine by a species of Arthrobacter. A novel catabolic role for "aminoacetone synthase". Biochem J (1969) 1.95
Rapid identification of Vibrio vulnificus on nonselective media with an alkaline phosphatase-labeled oligonucleotide probe. Appl Environ Microbiol (1993) 1.94
Identification of environmental Vibrio vulnificus isolates with a DNA probe for the cytotoxin-hemolysin gene. Appl Environ Microbiol (1987) 1.94
Quantitative optical phase microscopy. Opt Lett (1998) 1.88
Epidemiological usefulness of changes in hemolytic activity of Vibrio cholerae biotype El Tor during the seventh pandemic. J Clin Microbiol (1981) 1.88
The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun (1991) 1.87
Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect Immun (1992) 1.86
Screening for neural-tube defects and maternal anxiety. Br J Obstet Gynaecol (1982) 1.86
Superoxide dismutase in some obligately anaerobic bacteria. FEBS Lett (1975) 1.85
A multistate outbreak of hepatitis A caused by the consumption of raw oysters. Am J Public Health (1991) 1.85
HIV seroprevalence and reasons for refusing and accepting HIV testing. Sex Transm Dis (1994) 1.85
Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants. Thorax (2005) 1.83
Vibrio furnissii (formerly aerogenic biogroup of Vibrio fluvialis), a new species isolated from human feces and the environment. J Clin Microbiol (1983) 1.81
Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J Bacteriol (1992) 1.81